Septerna, Inc. Share Price
NASDAQ: SEPN | Small CapSepterna, Inc. Stock Performance
Open $40.44 | Prev. Close $39.55 | Circuit Range N/A |
Day Range $38.21 - $40.56 | Year Range $10.72 - $40.58 | Volume 17,422 |
Average Traded $39.27 |
Septerna, Inc. Share Price Today
As of 10 August 2026, Septerna, Inc.'s share price is $38.87. The stock opened at $40.44, compared to its previous close of $39.55. During today's trading session, Septerna, Inc.'s share price traded between $38.21 and $40.56, with an average price of $39.39. Over the past 52 weeks, the stock has recorded a high of $40.58 and a low of $10.72. In terms of performance, Septerna, Inc.'s share price has risen by 33.97% over the last six months and is up 221.73% on a year-on-year basis.
Septerna, Inc. Share Price Chart
Septerna, Inc. Stock Fundamentals & Key Indicators
Market Cap $1.72B | PE Ratio (TTM) -35.33 | Dividend Yield N/A |
EPS (TTM) $-1.10 | Revenue (TTM) $45.95M | Return On Equity (TTM) -12.80% |
Profit Margin -106.37% | Debt to Equity 0.23 | Quarterly Earnings Growth YoY 139.82% |
Septerna, Inc. Quarterly Profit & Loss
All figures in USD
Septerna, Inc. Annual Profit & Loss
All figures in USD
About Septerna, Inc.
Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. The company also develops oral small molecule single- and multi-incretin receptor agonists for metabolic disorders, including obesity and type 2 diabetes. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
Septerna, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $34.49 | $38.77 | +12.59% |
Jul 2026 | $33.45 | $34.44 | +2.65% |
Jun 2026 | $29.36 | $33.55 | +11.08% |
May 2026 | $23.93 | $30.20 | +27.08% |
Apr 2026 | $24.61 | $23.77 | -0.98% |
Mar 2026 | $28.01 | $24.00 | -17.27% |
Feb 2026 | $23.21 | $29.01 | +24.29% |
Jan 2026 | $28.30 | $23.34 | -15.91% |
Dec 2025 | $28.98 | $27.75 | -4.29% |
Nov 2025 | $20.71 | $29.00 | +40.95% |
Oct 2025 | $18.87 | $20.57 | +9.33% |
Sep 2025 | $12.26 | $18.82 | +55.79% |
SEPN Share Price FAQs
What is Septerna, Inc. share price today?
What is the 52 week high and 52 week low of Septerna, Inc. stock?
What is SEPN's market capitalisation today?
What is SEPN's net income for the last quarter?
What is the 5 year returns of SEPN?
What is the high & low stock price of SEPN today?
Can I buy SEPN shares in India?